Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 45,000 shares at $0.19 ($9K) on 2022-10-18, disclosed to the SEC on 2022-10-19.
Seasonal purchase ($9k) by Chairman and CEO, 10% Owner — this insider has traded EMMA in October in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.20 | 15,000 | $3K | 34.5% |
| 2 | $0.19 | 30,000 | $6K | 65.5% |
| Total | $0.19 avg | 45,000 | $9K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-17 | $17K | — | Filing → |